Category Archives: Glioblastomas

Crizotinib and children

Abstract 11509 covers 107 pediatric patients and their tumors. ALK alterations were found in 18 of them (not all are fusion mutations). The ages ranged from 3-16 years. 7 patients were still being treated at the data cut off. At … Continue reading

Posted in crizotinib - Xalkori from Pfizer, Glioblastomas, Neuroblastomas, Potential Treatments, Research, Side Effects | Leave a comment

New ALK inhibitor reported

According to the article summary, current ALK inhibitors do not inhibit the G1202R mutant of the ALK gene, which is one of the most common mutations. The researchers announced the development of a structural analogue of Alectinib (called JH-VIII-157-02) that … Continue reading

Posted in Brain metastases, Glioblastomas, JH-VIII-157-02, Lung cancer, Neuroblastomas, Potential Treatments, Research, Resistance to treatment | Leave a comment

Anti-ALK antibody research

The Ronan Thompson Foundation and Solving Kids’ Cancer award $80,000 grant to fund new therapeutic antibody research to treat children with neuroblastoma and other ALK+ cancers. The award of $80,000 was granted to the Children’s Hospital of Philadelphia (CHOP). Researchers … Continue reading

Posted in Glioblastomas, Neuroblastomas, Research | Leave a comment

Other Drugs

A place to post info on other potential drugs for which there is no specific page or for posting research that covers two or more different drugs.

Posted in Anaplastic Large-Cell Lymphomas, Glioblastomas, Lung cancer, Neuroblastomas, Potential Treatments, Research | Tagged | 23 Comments